Edward J. Estlin

541 total citations
10 papers, 380 citations indexed

About

Edward J. Estlin is a scholar working on Genetics, Neurology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Edward J. Estlin has authored 10 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Neurology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Edward J. Estlin's work include Glioma Diagnosis and Treatment (5 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Neuroblastoma Research and Treatments (3 papers). Edward J. Estlin is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Neuroblastoma Research and Treatments (3 papers). Edward J. Estlin collaborates with scholars based in United Kingdom, United States and France. Edward J. Estlin's co-authors include Tim Eden, Richard Alston, Anthony Moran, Jillian M. Birch, Ramandeep Singh Arora, Guy Makin, Deema Hussein, Caroline Dive, Chris J. A. Moulin and Marco Geraci and has published in prestigious journals such as European Journal of Cancer, Molecular Cancer Therapeutics and Neuro-Oncology.

In The Last Decade

Edward J. Estlin

10 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward J. Estlin United Kingdom 8 155 97 75 71 69 10 380
Taizo Shimomura Japan 11 96 0.6× 130 1.3× 67 0.9× 41 0.6× 25 0.4× 30 597
Octavio Arevalo United States 13 170 1.1× 104 1.1× 85 1.1× 138 1.9× 75 1.1× 43 505
Oğuz Baran Türkiye 11 65 0.4× 55 0.6× 82 1.1× 33 0.5× 21 0.3× 57 375
Amir Zolal Germany 12 219 1.4× 49 0.5× 102 1.4× 43 0.6× 68 1.0× 24 464
René Johannes Laursen Denmark 7 174 1.1× 95 1.0× 33 0.4× 83 1.2× 75 1.1× 15 385
Galal Elsayed United States 14 123 0.8× 96 1.0× 135 1.8× 48 0.7× 45 0.7× 39 574
Jinfang Liu China 12 68 0.4× 178 1.8× 57 0.8× 41 0.6× 90 1.3× 35 447
Tessa Hedley-Whyte United States 11 99 0.6× 50 0.5× 107 1.4× 46 0.6× 17 0.2× 13 506
Julia E. Neumann Germany 13 182 1.2× 131 1.4× 86 1.1× 51 0.7× 46 0.7× 37 388
Guido Ahle France 13 223 1.4× 81 0.8× 270 3.6× 49 0.7× 43 0.6× 42 577

Countries citing papers authored by Edward J. Estlin

Since Specialization
Citations

This map shows the geographic impact of Edward J. Estlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward J. Estlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward J. Estlin more than expected).

Fields of papers citing papers by Edward J. Estlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward J. Estlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward J. Estlin. The network helps show where Edward J. Estlin may publish in the future.

Co-authorship network of co-authors of Edward J. Estlin

This figure shows the co-authorship network connecting the top 25 collaborators of Edward J. Estlin. A scholar is included among the top collaborators of Edward J. Estlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward J. Estlin. Edward J. Estlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Grill, Jacques, Birgit Geoerger, Danuta Perek, et al.. (2013). Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study. Neuro-Oncology. 15(9). 1236–1243. 29 indexed citations
2.
Moulin, Chris J. A., et al.. (2012). Benefits and limitations of errorless learning after surviving pediatric brain tumors: A case study. Journal of Clinical and Experimental Neuropsychology. 34(6). 654–666. 3 indexed citations
3.
Geoerger, Birgit, Edward J. Estlin, Isabelle Aerts, et al.. (2011). A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: An Innovative Therapies for Children with Cancer (ITCC) study. European Journal of Cancer. 48(3). 289–296. 27 indexed citations
4.
Kamaly-Asl, Ian, et al.. (2011). Preoperative vincristine for an inoperable choroid plexus papilloma: a case discussion and review of the literature. Journal of Neurosurgery Pediatrics. 8(2). 149–153. 10 indexed citations
5.
Arora, Ramandeep Singh, Richard Alston, Tim Eden, et al.. (2010). Are reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979–2003. European Journal of Cancer. 46(9). 1607–1616. 42 indexed citations
6.
Moulin, Chris J. A., et al.. (2010). SenseCam as a rehabilitation tool in a child with anterograde amnesia. Memory. 19(7). 705–712. 42 indexed citations
7.
Estlin, Edward J.. (2010). Pediatric Hematology and Oncology. 4 indexed citations
8.
Ward, Evelyn, Nicola Williams, Sylwia Bujkiewicz, et al.. (2009). Nutritional problems in children treated for medulloblastoma: Implications for enteral nutrition support. Pediatric Blood & Cancer. 53(4). 570–575. 28 indexed citations
9.
Arora, Ramandeep Singh, Richard Alston, Tim Eden, et al.. (2008). Age–incidence patterns of primary CNS tumors in children, adolescents, and adults in England. Neuro-Oncology. 11(4). 403–413. 127 indexed citations
10.
Hussein, Deema, Edward J. Estlin, Caroline Dive, & Guy Makin. (2006). Chronic hypoxia promotes hypoxia-inducible factor-1α–dependent resistance to etoposide and vincristine in neuroblastoma cells. Molecular Cancer Therapeutics. 5(9). 2241–2250. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026